CRL
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHCharles River Laboratories International, Inc. Common Stock (CRL) [ST]
www.criver.com ↗▲ 5.38%
prev close
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
Congressional Trades
4
All tracked trades
Members Trading
4
Unique members
Net Activity
+2
3 buys · 1 sells
Members Who Traded This Stock
4 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-05-08 | CRLCharles River Laboratories International, Inc. Common Stock | Buy | $15,001 - $50,000 | 485d ago | — | |
| 2025-04-08 | CRLCharles River Laboratories International, Inc. Common Stock | Buy | $15,001 - $50,000 | 530d ago | — | |
| 2025-01-15 | CRLCharles River Laboratories International, Inc. Common Stock | Buy | $1,001 - $15,000 | 615d ago | — | |
| 2023-09-08 | CRLCharles River Laboratories International, Inc. Common Stock | Sell | $1,001 - $15,000 | 1106d ago | — |
2025-05-08
Jefferson Shreve
CRL
Amount
$15,001 - $50,000
Filed
485d ago
2025-04-08
Rob Bresnahan
CRL
Amount
$15,001 - $50,000
Filed
530d ago
2025-01-15
Julie Johnson
CRL
Amount
$1,001 - $15,000
Filed
615d ago
2023-09-08
Lois Frankel
CRL
Amount
$1,001 - $15,000
Filed
1106d ago
Recent News
Powered by Polygon.io
Global Synthetic Antibody Library Market Report 2026: Size and Forecast to 2030 | Capitalize on 12% CAGR and AI Design with Charles River, Twist Bioscience, GenScript and AbCellera
PGNY or CRL: Which Is the Better Value Stock Right Now?
Charles River Gains 75.8% in a Year: What's Driving the Rally?
Global Animal Model Market Report 2026-2034 by Animal Type, Technology, Application, End User, and Region | CRISPR and Drug Discovery Drive Growth to USD 3.31 Billion
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?
Trade Timeline
Congressional activity, newest first
Jefferson Shreve
2025-05-08 · Purchase
$15,001 - $50,000
Rob Bresnahan
2025-04-08 · Purchase
$15,001 - $50,000
Julie Johnson
2025-01-15 · Purchase
$1,001 - $15,000
Lois Frankel
2023-09-08 · Sale
$1,001 - $15,000